Latest Diamyd Medical News & Updates

See the latest news and media coverage for Diamyd Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Diamyd Medical

Clinical-stage diabetes therapy developer

diamyd.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
10–70

Last updated

Latest news about Diamyd Medical

In short: Diamyd Medical discontinued its Phase 3 DIAGNODE-3 trial following a futility analysis, leading to a CEO change and a strategic review.

Company announcements

Diamyd Medical

Diamyd Medical's CFO Niklas Axelsson resigns

He is leaving for a new role at another company. A review to find a successor is ongoing.

Unlock all announcements with a

Media coverage

The Wall Street Journal

Diamyd Medical AB Series B

1 Day DMYD.B 1.97% DJIA 0.58% Russell 2K 0.91% Health Care/Life Sciences 1.52...

Dagens industri

Diamyd has identified potential counterparties

Diamyd Medical has completed the initial phase of the strategic review initiated after the termination of the phase 3 study Diagnode-3.

Unlock all articles with a

Never miss news about Diamyd Medical

Track Diamyd Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.